Assessment of step-down of inhaled corticosteroids (ICS) in patients with controlled asthma
Not Applicable
Recruiting
- Conditions
- Bronchial asthma
- Registration Number
- JPRN-UMIN000011565
- Lead Sponsor
- Akira Yamasaki
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with uncontrolled co-morbid diseases such as cardio-vascular disease, cerebral disease, renal disease, endocrine disease and gastrointestinal disease. 2) Pregnancy and woman who is lactating or if of childbearing potential. 3) Treatment with oral corticosteroids or immunosuppressant therapy. 4) Patients with seasonal exacerbations and predicted worsen of symptoms within one year. 5) Unsuitable for the study in the judgment of their attending physician.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Severe exacerbation: requiring oral steroids, emergency visits or hospitalization [Time Frame: 12 months].
- Secondary Outcome Measures
Name Time Method Intermittent withdrawal of step-down judged by their attending physician according to worsen symptoms [Time Frame: 12 months].